Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Impaired glucose tolerance in COPD patients with hypoxaemia Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001
Reduced lung function is an independent risk factor for the development of impaired glucose tolerance? Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Measurement of pulmonary gas-exchange function at rest and during exercise Source: Annual Congress 2007 - PG2 - Respiratory physiology: pulmonary gas transfer and arterial blood gases Year: 2007
Increased anaerobic performance in CF-patients with impaired pulmonary function Source: Eur Respir J 2002; 20: Suppl. 38, 350s Year: 2002
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Reduced exercise capacity and impaired pulmonary function in patients with scleroderma Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Impaired TF following exercise is related to reduced lung capillary blood volume but is attenuated by an increase in the lung membrane diffusion capacity Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003
Impact of elevated pulmonary blood flow and capillary pressure on lung responsiveness Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009
A comparison about effects of different broncodilators on pulmonary function and exercise tolerance tests for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 63s Year: 2006
Clinical parameters and biomarkers for the early detection of impaired glucose tolerance in OSA patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Blood glucose levels determine glucose concentration of nasal secretions Source: Eur Respir J 2002; 20: Suppl. 38, 482s Year: 2002
Abnormal lung function and exercise test in children with the fontan circulation Source: Eur Respir J 2004; 24: Suppl. 48, 158s Year: 2004
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006
Physical activity, functional capacity, and anaerobic power in cystic fibrosis with and without impaired glucose tolerance Source: Virtual Congress 2020 – Physical activity and chronic lung disease Year: 2020
The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
Six-minute walk test: Comparison with cardiopulmonary exercise test performance, lung function and arterial blood gases in patients with bronchiectasis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
Airway: blood glucose ratio. A new pulmonary biomarker? Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006
The measurement of arterial blood gas lactate levels as a marker of tissue hypoxia in OSAS and overlap syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients Source: Eur Respir J, 57 (1) 2004265; 10.1183/13993003.04265-2020 Year: 2021